Nervgen Pharma NGEN
NASDAQ NGEN
$1.46 -0.04 (-2.67%)
As of: Oct 22, 2026 · 10:19 AM EDT

Nervgen Pharma (NGEN) Cash from Financing Activities (2025 - 2026)

Updated

Nervgen Pharma's Cash from Financing Activities came in at $56.49 million for the quarter ended Jun 30, 2026, compared with $3.43 million a year earlier.

Analysis

Nervgen Pharma (NGEN) Cash from Financing Activities (2025 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Nervgen Pharma reported Cash from Financing Activities of $62.84 million; for the year ended Dec 31, 2025, it came in at $17.01 million, up 2.6% from the prior year.

  • Going back by year, Cash from Financing Activities was $16.58 million in the year ended Dec 31, 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Eli Lilly 1,167.17 Bn 1,135.76 Bn 19.71 Bn 8.43 Bn
2 Johnson & Johnson 633.70 Bn 552.23 Bn 17.26 Bn -8.78 Bn
3 AbbVie 503.94 Bn 477.06 Bn 12.70 Bn -5.05 Bn
4 Merck 378.10 Bn 332.47 Bn 12.21 Bn 1.76 Bn
5 Novartis Ag 303.72 Bn 267.71 Bn 11.24 Bn -2.02 Bn
6 Astrazeneca 266.46 Bn 240.15 Bn 12.86 Bn -3.89 Bn
7 Amgen 241.07 Bn 196.47 Bn 7.24 Bn -1.48 Bn
8 Gilead Sciences 194.22 Bn 168.41 Bn 6.22 Bn 2.34 Bn
9 Pfizer 172.39 Bn 119.04 Bn 10.94 Bn -3.66 Bn
10 Nervgen Pharma 105.60 Mn 4.48 Mn - 56.49 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 56.49 Mn
Mar 31, 2026 2.03 Mn
Jun 30, 2025 3.43 Mn
Mar 31, 2025 888,133.63
API Access

Nervgen Pharma Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=NGEN&period=max&api_key=YOUR_API_KEY